Filter
51
Filtered Results: 51
Text search:
pharmacovigilance
policy
handbook
Featured
Recommendations
13
New Publications
15
Language
Document type
No document type
28
Guidelines
11
Manuals
6
Studies & Reports
3
Strategic & Response Plan
2
Training Material
1
Countries / Regions
Eastern Europe
4
Russia
3
India
3
Kenya
2
Global
2
Western and Central Europe
2
Ukraine
1
Ghana
1
Nigeria
1
Zimbabwe
1
Latin America and the Carribbean
1
Tanzania
1
South Africa
1
Uganda
1
Georgia
1
Zambia
1
Liberia
1
Authors & Publishers
Publication Years
Category
Clinical Guidelines
20
Countries
14
Key Resources
2
Capacity Building
1
Public Health
1
Toolboxes
TB
14
Pharmacy
5
AMR
4
NTDs
3
NCDs
2
Refugee
1
HIV
1
Ebola & Marburg
1
COVID-19
1
Kenya Essential Medicines List 2019
recommended
The Kenya Essential Medicines List 2019 is an indispensable guide to the medicines recommended for the management of common conditions in Kenya. It is primarily directed at health care providers and medicines supply managers in the public and non-public health sectors. It should be used together wit...
Diabetes is a significant public health issue that affects approximately one in 10 adults globally, with type 2 diabetes accounting for 90–95% of cases. This chronic condition causes considerable morbidity and mortality and is growing in impact, with cases projected to rise from 537 million in 202...
Framework for implementation.
The END TB Strategy.
The International Pharmaceutical Federation (FIP) is a global federation of national associations of pharmacists and
pharmaceutical scientists. In order to support these associations in their fight against AMR, FIP has prepared this
briefing document. It is an overview of the different activities ...
A living WHO guideline on drugs for covid-19
recommended
BMJ 2020; 370 doi: https://doi.org/10.1136/bmj.m3379
Rapid Recommendation and visual graph. This is the fifth version (update 4) of the living guideline (BMJ 2020;370:m3379). When citing this article, please consider adding the update number and date of access for clarity. The publication of the RE...
Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection
This manual summarizes key issues related to the safety of NTD medicines and their administration, with a focus on essential medicines used in mass drug administration (MDA), also called preventive chemotherapy. It can be used as a standalone reference manual, but is intended to be used in conjuncti...
Recommendations for a public health approach
2010 revision
Towards ending tuberculosis and multidrug-resistant tuberculosis.
The Global Action Plan on Antimicrobial Resistance (AMR) calls for making AMR a core component of professional education and training. In 2018, the World Health Organization (WHO) published Competency framework for health workers’ education and training on AMR to ensure that academic institutions ...
Это руководство предназначено для использования в качестве пособия дл яврачей и других медицинских работников, осуществляющих лечение и уход за больными лекарст...
WHO Guideline. Since 2010, countries in the meningitis belt have started to introduce a new serogroup A meningococcal conjugate vaccine conferring individual protection and herd immunity. Following the successful roll-out of this vaccine, epidemics due to Neisseria meningitidis serogroup A (NmA) are...
Guideline ‒ Alternative mass drug administration regimens to eliminate lymphatic filariasis
recommended
Lymphatic filariasis is a vector-borne neglected tropical disease that causes damage of the lymphatic system and can lead to lymphoedema (elephantiasis) and hydrocele in infected individuals. The global baseline estimate of persons affected by lymphatic filariasis is 25 million men with hydrocele an...
